ISOkine®

Highly Purified Plant-based
Animal Origin-Free, Growth Factors & Cytokines

Introducing the ORF Genetics' ISOkine® product range: Pioneering Innovation in PREMIUM, Highly Pure (>95%), Animal Origin-Free, Animal Component-Free (ACF), Endotoxin-Free, Recombinant Growth Factors & Cytokines. Explore our portfolio.

Explore our plant-based growth factors

Animal growth factors for the cultivated meat and other related industries
  • Animal Growth Factors
  • Plant-Based
  • Biorisk-free
  • With native barley seed proteins
Human and Mouse growth factors and other cytokines for stem cell research, regenerative medicine, and organoid production
  • Human and Mouse Growth Factors & Cytokines
  • Plant-Based
  • Animal Origin-Free, Animal Component-Free (ACF)
  • Highly Purified (>95%), Endotoxin-free
A defined barley seed extract with human-like growth factor activity, as proven by the award-winning skincare BIOEFFECT
  • Human Growth Factors
  • Plant-Based
  • For skin- and hair care
  • ISO 9001 certified

Milestone Tasting of Cultured Meat in Europe

We at ORF Genetics, and Australian novel food innovators, Vow, are proud to announce the success of its first of a kind cult​ured​ meat tasting in Europe on February 12th, 2024, featuring gourmet dishes created from the cells of Japanese quail.

We have Partnered up with SeaWith

We are very pleased to have partnered up with the South Korean company SeaWith to boost the production of cultivated meat using our MESOkine animal-free growth factors made from our barley plants

Barley Means Purity in Molecular Farming

Barley possesses unique characteristics, qualities that make it perfectly suited to our biotechnology needs. It is the perfect host for producing pure forms of specialty proteins such as human and animal growth factor.

Our Technology

Using plants to produce specialty proteins is called molecular farming. We have developed a unique expression system which uses barley grain as a vehicle for production of recombinant human and animal proteins.​ This has resulted in an extensive portfolio of recombinant proteins for stem cell technology research, skincare, biopharma, and the cultured meat market.